Department of Surgery, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, 431-3192, Japan.
Department of Perioperative Functioning Care and Support, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Esophagus. 2020 Jul;17(3):270-278. doi: 10.1007/s10388-020-00721-0. Epub 2020 Feb 6.
In April 2017, we launched the multidisciplinary Hamamatsu Perioperative Care Team (HOPE) for all surgical patients. We developed a reinforced intervention strategy, particularly for esophagectomy. We herein report the outcomes of the HOPE at 2 years after commencement.
A total 125 patients underwent esophagectomy and gastric conduit reconstruction for esophageal or esophagogastric junction cancer between January 2014 and December 2018 at the Department of Surgery in Hamamatsu University School of Medicine. The patients were divided into the pre-HOPE group including 62 patients who underwent esophagectomy before the introduction of the HOPE and the HOPE group including 63 patients who underwent esophagectomy after the introduction of the HOPE. The outcomes of surgery were compared between the two groups.
There were no significant differences in the clinicopathological characteristics between the two groups. The incidence rates of atrial fibrillation and pneumonia were significantly lower in the HOPE group than in the pre-HOPE group (6% vs. 19%, p = 0.027 and 14% vs. 29%, p = 0.037, respectively). The estimated calorie doses at the time of discharge were approximately 750 and 1500 kcal/day in the pre-HOPE group and the HOPE group, respectively. The body weight loss was significantly less in the HOPE group than the pre-HOPE group at 1, 3, 6, and 12 months postoperatively than that before the surgery (p < 0.001).
The introduction of the multidisciplinary HOPE was associated with a significant reduction in the incidence of postoperative pneumonia and significantly less weight loss.
2017 年 4 月,我们为所有手术患者启动了多学科滨松围手术期护理团队(HOPE)。我们制定了强化干预策略,特别是针对食管癌切除术。在此,我们报告 HOPE 启动后 2 年的结果。
2014 年 1 月至 2018 年 12 月,滨松大学医学院外科部为 125 例食管或食管胃交界癌患者行食管癌切除术和胃管重建术。患者分为 HOPE 前组(62 例,在 HOPE 引入前接受食管癌切除术)和 HOPE 后组(63 例,在 HOPE 引入后接受食管癌切除术)。比较两组手术结果。
两组患者的临床病理特征无显著差异。HOPE 组心房颤动和肺炎的发生率明显低于 HOPE 前组(6%比 19%,p=0.027 和 14%比 29%,p=0.037)。HOPE 组出院时的估计热量剂量约为 750 和 1500 kcal/天,HOPE 组和 HOPE 前组分别为 1500 和 1500 kcal/天。HOPE 组术后 1、3、6 和 12 个月的体重减轻明显少于 HOPE 前组(p<0.001)。
多学科 HOPE 的引入与术后肺炎发生率的显著降低和体重减轻明显减少相关。